4/A//SEC Filing
Radford Jason W. 4/A
Accession 0001209191-19-046731
CIK 0001131324other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:55 PM ET
Size
7.4 KB
Accession
0001209191-19-046731
Insider Transaction Report
Form 4/AAmended
Radford Jason W.
Chief Legal Officer
Transactions
- Sale
Common Stock
2019-02-19$83.73/sh−619$51,831→ 31,168 total - Sale
Common Stock
2019-02-19$83.03/sh−2,889$239,878→ 31,787 total
Footnotes (5)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 15, 2018.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $82.59 to $83.58.
- [F4]Includes an aggregate of 20,924 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $83.63 to $83.97.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001649199
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 7:55 PM ET
- Size
- 7.4 KB